EMA Wellness' GIANT™ Platform is the premier eCOA, digital data capture, clinical insight and adjudication solution for clinical trials.
The only purpose-built, single source code platform unifying data collection, signal flagging and real time remediation to ensure trial data quality from FPI to database lock
Core Features
How GIANT™ Transforms Clinical TrialsGIANT™ is EMAW’s unique, single code eCOA platform which has been on the market since 2018 and is currently being used in over 25 countries by more than 250 clinical research sites. With near real time data access, automated QC rules and visibility at the level of individual site, subject, and rater, GIANT™ acts as a resource multiplier for study sponsors and CROs.
Collect and integrate all primary, secondary and exploratory measures across data modalities (eCOA, EMA, sensor, wearable; audio and video). Use AI enabled transcription and hundreds of APIs to integrate third party data sets, including EMR/EHRs and structured real world databases.
Expert – designed rules are configured to review data as it is updated daily, with prespecified findings triggering time-based notifications, flags and alerts. To further enhance quality, AI transcription and review provide 100% coverage for large audio/video data files.
Targeted workflows: Detect potential issues and take remediation actions before they affect trial quality.
Advanced business intelligence: Interrogate data to build custom models and extract sponsor-specific insights beyond pre-configured analytics.
Full audit trails: Every keystroke logged, with automated compliance reports for sponsors/CROs.
Differentiation
While competitors stitch together disparate technologies, EMAW’s single-code architecture eliminates data errors, cuts costs by 30%, and slashes production timelines.
